Today: 20 March 2026
Subscribe
Browse Category

LSE:NWG.L 30 December 2025 - 18 January 2026

NatWest share price edges up as buyback rolls on and board change lands ahead of Feb results

NatWest share price edges up as buyback rolls on and board change lands ahead of Feb results

NatWest shares rose 0.2% to 630.0 pence in early London trading after the bank disclosed it bought back 845,398 shares on Jan. 13, to be cancelled. The stock remains 6.7% below its Jan. 6 high. Non-executive director Yasmin Jetha will retire in March, with Albert Hitchcock joining the board in February. Investors await NatWest’s annual results and 2026 guidance on Feb. 13.
14 January 2026
·
NatWest share price drops after Barclays downgrade as buybacks and earnings come into focus

NatWest share price drops after Barclays downgrade as buybacks and earnings come into focus

NatWest shares dropped 2.7% to 642.8 pence after Barclays downgraded the stock to “equal weight.” The bank continued its £750 million buyback, purchasing 787,737 shares Tuesday. Barclays trimmed 2026-27 earnings estimates by 4% and warned rising risk-weighted assets could limit surplus capital. Investors await NatWest’s Feb. 13 results for updates on margins and capital targets.
7 January 2026
··
Lloyds pulls invoice factoring for SMEs, tightening cash‑flow options heading into 2026

Lloyds pulls invoice factoring for SMEs, tightening cash‑flow options heading into 2026

Lloyds Banking Group will close its invoice factoring service for small and medium-sized businesses by the end of 2025, according to the Financial Times. NatWest and Barclays have already scaled back similar offerings, while HSBC has tightened eligibility. Less than 1% of Lloyds’ SME clients use the service. The move comes as small firms face rising costs and persistent late payments.
30 December 2025
···
1 2

Stock Market Today

  • Centene Launches Community Programs Amid Depressed Stock Price: What Investors Should Know
    March 20, 2026, 6:30 AM EDT. Centene Corp subsidiaries have initiated community-focused programs targeting behavioral health, job training, housing support, and diabetes care, aiming to assist underserved populations across major U.S. markets. These efforts come as Centene shares (NYSE:CNC) remain under pressure, with a recent price of $35.57, down 13.7% in the past month and 40.3% over one year. Investors should monitor these initiatives closely for insights into Centene's regulatory relations and potential impact on medical loss ratios and membership retention. Despite current headwinds, the stock trades nearly 17% below analyst targets and is marked as undervalued by Simply Wall St. Key risks include rising costs without clear reimbursement or measurable health outcomes.
Go toTop